Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1987-10-01
1989-10-24
Pal, Asok
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
546245, 548407, 548540, 548953, 549265, 549321, 549323, C07D20700
Patent
active
048763594
ABSTRACT:
Novel .gamma.-butyrolactone derivatives having strong ACE inhibitory activity are provided. They are represented by the following general formula (I): ##STR1## wherein R.sup.1 and R.sup.2 may be the same or different and mean individually a hydrogen atom or a straight-chain or branched alkyl or cycloalkyl group, or R.sup.1 and R.sup.2 are bonded together to mean an alkylene group having 2-6 carbon atoms, R.sup.3 denotes a hydrogen atom or a lower alkyl, aralkyl, amino lower alkyl or lower alkoxycarbonylamino lower alkyl group, R.sup.4 means a lower alkyl, cycloalkyl or aralkyl group, R.sup.5 means a hydrogen atom or a lower alkyl group, or R.sub.4 and R.sub.5 are bonded together to denote an alkylene group having 2-4 carbon atoms, and R.sup.6 stands for a hydrogen atom or a lower alkyl or aralkyl group; or a pharmacologically acceptable salt thereof.
REFERENCES:
patent: 4310463 (1982-01-01), Chan
patent: 4613613 (1986-09-01), Oguri et al.
Hasegawa Hiroshi
Katori Tatsuhiko
Narita Tadashi
Shioiri Noriaki
Pal Asok
SS Pharmaceutical Co., Ltd.
LandOfFree
Novel gamma-butyrolactone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel gamma-butyrolactone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel gamma-butyrolactone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1590247